Chambers Michael Andrew
- SEC CIK
- 0001932527
No open-market purchases or sales filed in the past year.
Current role at each company
- SRPT Sarepta Therapeutics, Inc.Directoras of Jun 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Chambers Michael Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2024 (view filing) | Aug 16 | 4 days | Chambers Michael AndrewDirector | PPurchase | +37.0K | $133.80 | +$4.96M | +15.0%284.0K after | 3 lots |
| Aug 15, 2023 (view filing) | Aug 14 | 1 day | Chambers Michael AndrewDirector | PPurchase | +9.98K | $109.47 | +$1.09M | +4.2%247.0K after | 2 lots |
| Aug 14, 2023 (view filing) | Aug 11 | 3 days | Chambers Michael AndrewDirector | PPurchase | +23.7K | $108.05 | +$2.56M | +11.1%237.0K after | |
| Aug 11, 2023 (view filing) | Aug 10 | 1 day | Chambers Michael AndrewDirector | PPurchase | +34.9K | $106.15 | +$3.70M | +19.5%213.3K after | 3 lots |
| Sep 15, 2022 (view filing) | Sep 14 | 1 day | Chambers Michael AndrewDirector | PPurchase | +57.1K | $104.43 | +$5.96M | +111.8%108.2K after | 3 lots |
| Aug 22, 2022 (view filing) | Aug 19 | 3 days | Chambers Michael AndrewDirector | PPurchase | +46.2K | $108.28 | +$5.00M | +940.7%51.1K after | 2 lots |